Epirubicin and neutrophil count decreased Patient Reports February 12, 2012

Epirubicin Side Effects Report #4808931-5
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2005. Male patient, weighting 94.80 lb, was diagnosed with gastric cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: chills, constipation , febrile neutropenia, laboratory test abnormal, neutrophil count decreased, treatment noncompliance. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5282098-4
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Mar 23, 2007. Female patient, 64 years of age, weighting 125.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: deep vein thrombosis , neutrophil count decreased. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADCAL, ZOMETA. Patient died on 08/21/2006.

Epirubicin Side Effects Report #5122759-0
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Sept 25, 2006. Female patient, 64 years of age, weighting 125.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: deep vein thrombosis , neutrophil count decreased. Epirubicin dosage: 140 MG TOTAL IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADCAL, ZOMETA. Patient died on 08/21/2006.

Epirubicin Side Effects Report #5840738-2
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Aug 01, 2008. Female patient, 64 years of age, weighting 125.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: deep vein thrombosis , neutrophil count decreased. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADCAL, ZOMETA. Patient was hospitalized. Patient died on 08/21/2006.


Epirubicin Side Effects Report #5104079-3
Epirubicin side effect was reported by a Physician from JAPAN on Aug 29, 2006. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, lung disorder, neutrophil count decreased, white blood cell count decreased. Epirubicin dosage: 90 MG (90 MG, FREQUENCY: QD) INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Epirubicin Side Effects Report #5099700-2
Epirubicin side effect was reported by a Health Professional from AUSTRALIA on Aug 23, 2006. Female patient, 44 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, neutrophil count decreased, white blood cell count decreased. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, TRIPTORELIN ACETATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4677165-X
Epirubicin side effect was reported by a Health Professional from on May 16, 2005. Male patient, 64 years of age, weighting 172.0 lb, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hyperhidrosis, hypocalcaemia, neutrophil count decreased, ph body fluid abnormal, productive cough, pyrexia, white blood cell count decreased. Epirubicin dosage: (100 MG) INTRAVENOUS. During the same period patient was treated with CISPLATIN, CAPECITABINE, METOCLOPRAMIDE, DEXAMETHASONE, TINZAPARIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4698076-X
Epirubicin side effect was reported by a Health Professional from on May 16, 2005. Male patient, 64 years of age, weighting 172.0 lb, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood ph abnormal, hyperhidrosis, hypocalcaemia, neutrophil count decreased, productive cough, pyrexia, white blood cell count decreased. Epirubicin dosage: (100 MG) INTRAVENOUS. During the same period patient was treated with CISPLATIN, CAPECITABINE, METOCLOPRAMIDE, DEXAMETHASONE, TINZAPARIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.